The Rising Gray Market for Peptides: Trends, Risks, and Impacts

By Patricia Miller

Jun 05, 2026

2 min read

The gray market for peptides is rapidly growing, driven by trends like TikTok, with significant financial inflows and serious safety concerns.

#What is driving the growth of the peptide gray market?

The booming gray market for peptides, injectable compounds that claim to offer benefits like weight loss and anti-aging, is becoming increasingly significant. Recent reports reveal that inflows to peptide vendors surged dramatically, indicating burgeoning interest and investment in this sector.

According to a Chainalysis report released on June 4, 2026, the inflows to identified peptide vendors skyrocketed from $12 million in the final quarter of 2025 to a staggering $32 million in the first quarter of 2026, marking a remarkable 159% growth in just three months. The projections for the second quarter suggest that inflows may reach up to $39 million, suggesting an annualized run rate that could exceed $100 million.

The rise of the viral "looksmaxxing" trend on TikTok has played a crucial role in elevating the demand for off-label analogs of GLP-1 receptor agonists, which include well-known drugs like Ozempic and Wegovy. Users on the platform frequently share methods for combining various peptides, from those aimed at weight management to growth-related substances, often without any medical guidance.

Chainalysis has identified a shift in certain Chinese chemical manufacturers who initially focused on producing fentanyl precursors and amphetamines. They have now redirected their business models to cater to the peptide market, as exemplified by Shanghai Sigma Audley, which transitioned from selling fentanyl precursors to peptides while using the same contact methods and digital wallets. Another case is Shanghai ERP Peptide Biotechnology, which received approximately $3.6 million in digital payments within a few months.

An analysis of transaction patterns indicates a distinct preference among peptide vendors regarding payment methods. For larger vendors handling average transactions of $1,000 or more, stablecoins have emerged as the dominant choice over Bitcoin. This shift highlights the evolving landscape of payment solutions in the gray market.

#What are the safety concerns surrounding peptide use?

The alarming decline in spending on independent lab testing poses significant risks in this market. Reports indicate an estimated 88% drop in testing expenditures per buyer. Even though total testing volume has increased slightly, the number of buyers taking the initiative to verify the substances they inject has sharply decreased.

Given that these are injectable substances, the lack of safety oversight could lead to serious health issues, including infections or abscesses. As this market grows, addressing the safety concerns becomes paramount for both users and regulators.

Important Notice And Disclaimer

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.